MedPath

Influence of the Menstrual Cycle on the QT interval in females with Long QT-syndrome

Conditions
long QT syndrome
LQTS
10007521
10007510
Registration Number
NL-OMON54957
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Genetically confirmed LQT1 or LQT2
Age between 12 and 30 years

Exclusion Criteria

Pregnancy and post-partum period until the end of breastfeeding
The use of hormonal contraceptive therapy other than combined
oestrogen-progestin oral contraceptives (i.e. intrauterine contraception,
contraceptive vaginal ring, etonogestrel contraceptive implant, injectable
contraceptives or progestin pills)
History of anorexia nervosa or polycystic ovary syndromeHistory of anorexia
nervosa or PCOS
BMI for age greater or less than the 99th percentile
Double mutation carrier or compound heterozygote
Mutations of unknown pathogenicity

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Concomitant estradiol and pregnanediol fluctuations will be obtained together<br /><br>with the QTc at three time points during the menstrual cycle or approximately<br /><br>corresponding with the phases of the menstrual cycle in LQTS-females with and<br /><br>without HCT, respectively. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Daily QTc fluctuations during 1 month in men and women both with and without<br /><br>HCT. </p><br>
© Copyright 2025. All Rights Reserved by MedPath